M11.859
Other specified crystal arthropathies, unspecified hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Other specified crystal arthropathies refer to a group of joint disorders caused by the buildup of crystals in the joints, leading to pain, swelling, and inflammation. When these conditions affect the hip, they can significantly impact mobility and quality of life. ICD-10 code M11.859 specifically describes these types of crystal-related joint issues in the hip that have not been classified under more common types or specifics.
Causes & Symptoms
Clinical Causes: Excessive uric acid in the blood leading to crystal deposits, often associated with gout Presence of calcium pyrophosphate dihydrate (CPPD) crystals causing pseudogout Metabolic disorders affecting crystal formation Genetic predisposition influencing crystal deposition Joint trauma or injury that may predispose to crystal accumulation Chronic kidney disease impairing crystal excretion Certain medications that alter mineral metabolism
Key Symptoms: Sudden or gradual onset of joint pain Swelling and tenderness in the affected hip Reduced range of motion or difficulty moving the hip Warmth and redness around the joint Stiffness, especially after periods of inactivity Possible fever if inflammation is severe episodes of acute flare-ups interspersed with periods of remission
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation, imaging, and laboratory tests. Key steps include: - Physical examination assessing joint swelling, tenderness, and range of motion - Imaging studies such as X-rays to observe joint damage or crystal deposits - Arthrocentesis, which involves extracting joint fluid and analyzing it under a microscope to identify crystals - Blood tests measuring uric acid or calcium levels to assess for underlying metabolic causes - Exclusion of other joint disorders to confirm crystal arthropathy specific to the hip
Treatment Protocols: Treatment strategies aim to reduce inflammation, manage pain, and prevent joint damage. Common approaches include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to alleviate pain and inflammation - Colchicine, often used during flare-ups to reduce crystal formation and inflammation - Corticosteroid injections directly into the joint to control severe inflammation - Lifestyle modifications such as dietary changes to lower uric acid levels and maintain a healthy weight - Managing underlying metabolic disorders contributing to crystal formation - Physiotherapy to improve joint function and mobility - In some cases, surgical intervention may be necessary for severe joint damage
Clinical Advice & FAQs
Billing Guidance
Is M11.859 a billable ICD-10 code?
Yes, M11.859 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.859?
Clinical documentation must specify the nature of Other specified crystal arthropathies, unspecified hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference